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A B S T R A C T
Candidiasis is defined as an infection or disease caused by a fungus of the genus Candida. Rate of disseminated
candidiasis increases with the growth of the number of immunocompromised patients. In the the last few decades the in-
cidence of disseminated candidiasis is in growth as well as the mortality rate. The aim of this survey is to show the im-
portance of serological tests implemenation in disseminated candidiasis diagnose. This is a prospective study involving
60 patients with malign diseases with and without clinical signs of disseminated candidiasis and 30 healthy people who
represent the control group. Apart from hemoculture, detection of circulating mannan antigen and adequate antibodies
of Candida species applying comercial ELISA test was determined in each patient. This survey deals with relevant fac-
tors causing disseminated candidiasis. This survey showed that the group of patients with clinical signs of disseminated
canididiasis had more patients with positive hemoculture to Candida species, then the group of patients without clinical
signs of disseminated candidiasis. The number of patients being examined and positive to antigens and antibodies was
higher (p<0.01) in the group of patients with clinical signs of disseminated candidiasis (7/30; 23.3%), then in the group
of patients without clinical signs of disseminated candidiasis (0/30; 0%). Average value of titra antigen was statistically
higher (p<0.001) in patients with Candida spp. positive hemocultures rather then in patients with Candida spp. nega-
tive hemocultures. In the group of patients with clinical signs of disseminated candidiasis 6/30 (20%) of patients had
Candida spp.positive hemocultures while in the group of patients without clinical signs of disseminated candidiasis
1/30 (3.3%) of patients had Candida spp. positive hemocultures, which was considerably higher (p<0.05). Correlation of
results of hemoculture and mannan antigens and antibodies in patients with disseminated candidiasis were statistically
significant, while correlation of results of hemoculture and antibodies was insignificant. Because of low sensitivity of
hemoculture and time needed for isolation of Candida spp., introducing serological tests in regular procedures would
speed disseminated candidiasis diagnose.
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Introduction
Disseminated candidiasis is defined as multiorganic
fungus infection caused by species of genus Candida
with or without candidemia1. This infection usually in-
volves brain, kidneys, heart, eyes and other organs and
systems. The rate of disseminated candidiasis grows with
the increase of immunocompromised patients and it is
also connected with invasive interventions especially in
departments of intensive care unit. Yeasts are major
cause of infections and they take the fourth place among
microorganisms which are isolated in hemocultres (4.9%)2.
In the last few decades the incidence of disseminated
candidiasis is noticed and it takes 8 cases per 100000 of
the population in the USA. According to Centre of Dis-
ease Control (CDC) and Departments of Bacteria and
Fungus Infections data the rate of mortality is 30–50%.
Gastrointestinal tract (0.55%), vagina (2.2–68%), and
skin (approximately 2%) represent the large reservoir of
Candida albicans (C. albicans). After impairing the mu-
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cosa of gastrointestinal tract Candida can expand to dif-
ferent organs leading to disseminated infection. Patients
with hematological impairment, patients with impair-
ment of organs, patients who had bone marrow trans-
plantation, patients who had operated gastrointestinal
tract or heart, patients with hard burns, patients with
prolonged intravein catheterization, and patients with
diabetes mellitus are prone to disseminated candidiasis3.
The risk factors for Disseminated candidiasis are neutro-
penia and impaired mucosa as a consequence of chemo-
therapy or X-rays as well as prolonged use of antibiotics4.
Clinical signs of disseminated candidiasis are unspe-
cific. The most common clinic signs are fever, sepsis,
changes on the skin and retina. These symptoms can be
found in other diseases as well which makes it harder to
diagnose disseminated candididasis. Fever and sepsis do
not react to therapy of large spectrum antibiotics and
they are very often the only clinical signs of acute dis-
seminated candidiasis. Making an early diagnosis of dis-
seminated candidiasis is very hard, since the clinical
signs and symptoms are very unspecific which postpones
beginning of antifungal therapy. The classic diagnose of
disseminated candidiasis is based on isolation of Candida
species (Candida spp.) from blood and on histopatho-
logical and microbiological analyses of the bioptical ma-
terial. Disadvantages of these diagnosing prcedures are
evident in low sensitivity of ones while the others are
very invasive and often impossible to do in practice5.
Apart from these methods serology methods have de-
veloped lately and they are based on detection of antibod-
ies and antigens of Candida from body fluids. They rep-
resent the early specific markers of disseminated
infection6. The basic advanatge of serology method in
comparison to classic labaratory method is that the re-
sult is given within few hours with specificity of 93% and
sensitivity of 80%, while hemoculture becomes positive
in 2 to 5 days an it remains negative in 50% of cases7. An-
tibodies and mannan antigen detection tests can be made
with double immunodiffusion (ID) and enzyme immuno-
assay (ELISA-Platelia Candida antibody test). Mannan
antigen detection is performed by several techniques like
radioimmunoassay (RIA), enzyme imunnoassay (ELI-
SA), latex agglutination (LA) and reserve passive latex
agglutination (RPAL). ELISA test is based on detection
of á–oligo mannose from serum which is released from cell
walls during Candida infection8. Combination of these
two test, detection of antibodies and antigens, leads to
higher specificity and sensitivit in early disseminated
candidiasis diagnose as well as early usage of antifungal
therapy9.
Aims of Survey
1) To define serum values of manan antigen and anti-
bodies in patients with clinical signs of disseminated
candidiasis.
2) To correlate the results of hemoculture with the re-
sults of specific antigen of Candida spp. (mannan anti-
gen) and antibodies in patients with clinical signs of
disseminated candidiasis.
Materials and Methods
This survey was made at Clinic for Laboratory Diag-
nosis, Department of Microbiology, University Clinic
Centre in Tuzla. This survey includes 90 patients. Test
group I was made of 30 immunocompromissed patients
(patients with malign diseases who underwent cytostatic
therapy) with clinical signs of disseminated candidiasis.
Test group II was made of 30 immunocompromissed pa-
tients (patients with malign diseases who underwent
cytostatic therapy) without clinical signs of disseminated
candidiasis. Clinical signs which included patients in test
group I were:
¿ neutropenia <1.5 x 109/L lasting longer than 10
days
¿ fever-lasting more than 96 hours without any re-
sponse to antibiotic therapy
¿ body tempertaure higher than 38 °C.
Control group was made of 30 healthy adults (blood
donors) whose samples were recived from Department of
Transfusiology from University Clinic Centre in Tuzla.
From histories of diseases of patients personal data was
taken (name, surname, date of birth and gender/sex).
Apart from this data, relevant data for making dissemina-
ted candidiasis diagnose like information about disease,
information about any antibiotic therapy, information
about values of neutrophil leucocytes and information
about body temperature was also taken. To perform mi-
crobiological examination 10 ml of blood for hemoculture
and 3 ml of blood for serology testing was taken from
each patient. In original basis for hemoculture BD Bactec
Mycosis IC/F 10 mL of blood was put and cultivated for
14 days on 30 °C in the machine for automatic detection
Bactec 9120 (Becton, Dickinson and Company). After the
signal which marks the increase of yeasts in hemoculture
the same were disseminated to SDA, Malt Agar an incu-
bated for 48 hours on 27 °C. Identification of increased
colonies of Candida was made by standard mycological
procedures (microscope, germination test and chlamydo-
spore test). Germ tube test was made by incubation of in-
creased colonies of yeasts from nutrient foundation (opti-
mal inoculum 104–16 cells per mL), on 37 °C in 10%
human serum for two hours. The result of blastospor
with formed cylinder shoots which were 8–10 mm long
and 2–3 mm wide was considered as a positive test.
Proving the ability of making hlamidospore was done by
cultivating increased colonies of yeasts of potato agar,
which was incubated 3–5 days on 27 °C in a humid cham-
ber. The result of characteristic terminal, intercalar and
lateral hlamidospore on pseudohyphae of yeasts was
marked as positive test. Apart from standard mycro-
biological methods for detection of yeasts of Candida
species automatic system for identification of microor-
ganisms was also used applying VITEK 2 Compact appa-
ratus. The presence of antibodies in mannan antigen C.
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species was determined by applying ELISA Platelia Can-
dida-specific Ab test (Bio-Rad Laboratories) and the
presence of mannan antigen was determined by applying
ELISA Platelia Candida-specific Ag test (Bio-Rad Labo-
ratories). Performing of the tests was made by instruc-
tions of manufacturer8. All samples with concentration
of mannnan antigen lower than 0.25 ng/mL (C<0.25)
were marked as negative. If the concentration of antigen
was betweeen 0.25 and 0.5 ng/mL (0.25£C<0.5) the tests
were marked as intermediary. Concentration of mannan
antigen higher or equal to 0.5 ng/mL (C³0.5) was marked
as positive. All samples of serum with concentration of
anti-mannan At lower than 5 AU/mL (C<5) were consid-
ered negative. Samples of serum with concentration of
anti-mannan At between 5 and 10 AU/mL (5£C<10)
were considerd as intermediary. Samples of serum with
concentration of anti-mannan At higher or equal to 10
AU/mL (C³10) were considred as positive.
Statistical data treatment
In statistical data treatment standard method of de-
scriptive statistics (correlation of values) was used. For
testing statistical significance between the groups para-
metric and unparametric tests, student’s t-test, Spear-
man’s coefficient of correlation and ANOVA were used.
Statistical hypothesis was tested on p=0.05 level, i.e. the
difference between the groups was considered as impor-
tant if p<0.05.
Results
From the total of 90 patients 30 belong to control
group. From the remaining 60 patients, 37 (61%) of them
were with hematological and 23 (39%) of them were with
oncological types of malignity. Presence of patients in
both groups according to the type of malignity was 7/60
of patients with double antifungal therapy and 11/60 pa-
tients with at least one antifungal in their therapy. 42/60
of patients did not have antifungal s included in their
therapies. In the group of patients who did not have
antifungal s in their therapy 5/42 (11.9%) was with posi-
tive hemoculture. In the group of patients who had
antifungal s in their therapy 2/18 (11.1%) was with posi-
tive hemoculture. This difference is not statistically sig-
nificant. More (p<0.001) patients with positive antigen
was found among the patients who did not have anti-
fungal therapy (10/15; 66.7%) in comparison to patients
who had antifungal therapy (3/45; 6.7%) (Figure 1).
There was not any significant difference between the
presence of antibodies in the group of patients who had
(23/45; 51.1%) and in the group of patients who did not
have (9/15; 60%) antifungal therapy (p>0.76).
In both groups 2/60 of patients had 4 antibiotics in
their therapy, 13/60 of patients had triple AB therapy,
15/60 of patients had double therapy nad 11/60 of pa-
tients had at least one antibiotic in their therapy. 19 of
patients did not have any antibiotics in their therapy. In
the group of patients with clinical signs of disseminated
candidiasis all patients had antibiotic therapy 30/30. In
the group of patients without clinical signs of dissemi-
nated candidiasis 11/30 (36.6%) of patients had antibiotic
therapy which was statistically significant.
Values of body temperature
Average body temperature in the group of patients
with clinical signs of disseminated candidiasis was 38.8±
0.4 °C, while the average body temperature in the group
of patients without clinical signs of disseminated candi-
diasis was 37.6±0.8 °C. It was approximately higher for
1.19 degrees (%95CI = 0.9–1.5), which was statistically
significant difference (p<0.001). The body temperature
of all patients in the control group was normal.
Values of neutrophil leucocytes
The values of neutrophil leucocytes were lower (p<
0.001) in patients with clinical signs of disseminated
candidiasis (0.69±0.36), in comparison to patients with-
out clinical signs of disseminated candidiasis (2.82±
2.27), with approximate difference of 2.13 (%95CI =
1.29–2.97). The control group had normal values of neu-
trophil leucocytes (Figure 2). 13/30 (43.3%) of patients
had the values of neutrophil leucocytes <0.5 x 109/L.
From these in 2/13 (15.3%) of patients disseminated
candidiasis was proved.
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Fig. 1. The correlation of applied antifungal therapy and
the presence of mannan antigen.
Fig. 2. Relation of values of neutrophil leucocytes in patients
with and without clinical signs of disseminated candidiasis.
Titra antibodies and antigen values analysis
with the results of hemoculture
In the group of patients with clinical signs of dissemi-
nated candidiasis 6/30 (20%) of patients had positive
hemoculture to Candida. In the group of patients with-
out clinical signs of disseminated candidiasis 1/30 (3.3%)
of patients had positive hemoculture to Candida, which
was statistically higher (p<0.05).
Average value of titra antibodies in patients who had
positive hemoculture to Candida was 20.7±16.1 AU/mL
while average value of titra antibodies in patients who
had negative hemoculture to Candida was 13.7±15.5
AU/mL. This was not statistically significant (p=0.94),
as shown in Figure 3. The average value of titra antigen
(0.86±1.05) ng/mL was statistically higher in patients
with positive hemoculture (p<0.001), in comparison to
patients with negative hemoculture (0.13±0.45) ng/mL,
with approximate difference of 0.73 (%95CI = 0.30–
1.17). This difference is shown in Figure 4. The average
value of titra antigen in the control group was 0, while
the average value of titra antibodies was 0.02. This num-
ber is lower in the comparison to the other two examined
groups (p<0.05).
Average values of titra antigen and titra
antibodies in patients
The average values of mannan antigen in the group of
patients with clinical signs of disseminated candidiasis
was 0.43±0.78, which was statistically more (p<0.05)
than in the group of patients without clinical signs of dis-
seminated candidiasis as well as in the control group,
where there were not any patients with detectable values
of this antigen. The average values of antibodies were
higher (p<0.05) in the group of patients with clinical
signs of disseminated candidiasis (15.85±16.24), in com-
parison to the group of patients without clinical signs of
disseminated candidiasis (13.24±15.0), and in compari-
son to the control group (0.01±0.06). The number of pa-
tients who were positive to antigen and antibodies was
higher (p<0.01) in the group of patients with clinical
signs of disseminated candidiasis (7/30; 23.3%), than in
the group of patients without clinical signs of dissemi-
nated candidiasis (0/30; 0%) (Figure 5). The number of
patients who were positive to antigens and antibodies
was higher (p<0.01) in the group of patients with posi-
tive hemoculture (3/7; 42.9%), in comparison to the
group of patients who had negative hemoculture (4/53;
7.5%) (Figure 6).
Correlation of results of antigens and
antibodies with hemoculture
The results of hemoculture and the results of mannan
antigens and antibodies in patients with clinical signs of
disseminated candidiasis were correlated. It was proved
that there was statistically significant correlation be-
tween the results of hemoculture and mannan antigen
(r=0.36; p<0.05), while the correlation of results be-
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Fig. 3. Relation of values titra antibodies and hemoculture.
Fig. 4. Relation of values titra antigen and hemoculture.
Fig. 5. Relation of positive results of antigens and antibodies in
patients with and without clinical signs of Disseminated candi-
diasis.
Fig. 6. Relation of positive results of antigens and antibodies
and hemoculture.
tween the hemoculture and antibodies was unsignificant
(r=0.25; p=0.19). ROC (Receiver Operating Characteris-
tics) analysis of diagnostic values of mannan antigen for
prediction of positivity of hemoculture to Candida spe-
cies was made (although this is a bad standard because
Candida spp. is positive in 50% of cases). ROC space was
0.75 (%95CI = 0.65–0.84; p<0.05) and was statistically
significant (Figure 7). The best diagnostic test perfor-
mance on classifying positive hemoculture had predictive
value 0,45, which had sensitivity of 57% and specifity of
98%, and PPV of 67% and NPV of 96%.
Discussion
Disseminated (systematic, invasive, hematogenic)
candidiasis involves blood stream infections and inner
organ infections, which are caused by penetration of
Candida species yeasts into bloodstream. Frequency of
these infections increases with the number of immu-
nocompromissed patients, but it is also connected to in-
vasive operations in departments of intense care. The in-
cidence of candidemia is higher in Barcelona than in the
USA (4.3 cases per 100 000 of the population) and it was
6 to 10 cases per 100 000 of the population10. The inci-
dence of candidemia in North European countries is
from 1.7 to 4.9 of cases per 100 000 of the population11. In
comparison to results from USA the higher incidence
rate is result of demographic factors and applying of dif-
ferent medical procedures. According to literature data
in our country there were not any similar researches un-
til today, which could give the exact estimate of incidence
of candidiasis and its exposure. The percentage of the
whole number of patients with candidemia in compari-
son to the number of patients with septicemia was 5% in
the USA, and in European Countries it was 2–3%12. In
Croatia, in 23.3% of patients with septicemia fungus eti-
ology was confirmed13. In our reserach 11% of patients
had candidemia 21% of patients had positive mannan an-
tigen result which is, according to many authors, consid-
ered as indication of candidemia. Higher percentage of
proved candidemia is explained by a good analyzed
group. Fungus Infection Group at The European Organi-
sation for Research and Treatment of Cancer (EORTC),
has shown the difference in distribution of Candida spe-
cies in patients with hematological malignities and in pa-
tients with solid tumors in their research. From 294 of
patients 36% had oncological type of malignity and 64%
had hematological type of malignity14. This research has
shown that from 60 patients 61% of them had hemato-
logical type of malignity and 39% of patients had onco-
logical type of malignity which matches with the litera-
ture data. Clinical signs and biochemical parameters
showing the most predictive value in disseminated can-
didiasis diagnose are fever (body temperature higher
than 38 °C) which do not react to antibiotic therapy and
which has values of neutrophil leucocytes lower than
0.5 x 109/L. Fever lasting for 3 and more days and with-
out any reaction to antibiotic therapy and values of
neutropenia lower than 0.5 x 109/L is basic criteria for
disseminated candidiasis diagnose15. In our research in-
creased body temperature (>38 °C) lasting for 3 and
more days and without any reaction to antibiotic therapy
was one of the including signs for clinical diagnosis of
disseminated candidiasis. Average body temperature in
the group of patients with clinical signs of disseminated
candidiasis was 38.8±0.40 °C. Average body temperature
in the group of patients without clinical signs of dissemi-
nated candidiasis was 37.6±0.80 °C. It was approximately
higher for 1.19 degrees (%95CI = 0.9–1.5), which was sta-
tistically significant difference (p<0.001). In both groups
2/60 of patients had 4 antibiotics in their therapy, 13/60
of patients had triple AB therapy, 15/60 of patients had
double therapy nad 11/60 of patients had at least one an-
tibiotic in their therapy. 19 of patients did not have any
antibiotics in their therapy. Prolonged neutropenia (which
takes longer than 10 days and with values <0.5 x 109/L)
is one of the most important factors which classifies pa-
tients with hematological malignities into the most risk-
ing group for getting disseminated candidiasis. In the
research15, 79% of patients had neutropenia (<0.5 x
109/L) approximately for 20 days before the signs of dis-
seminated infection, while in 11% of patients dissemi-
nated candidiasis was proved. In our research all pa-
tients with clinical signs of disseminated candidiasis had
neutropenia which lasted longer than 10 days with val-
ues <1.5 x 109/L. 43.3% of patients had neutrophil values
<0.5 x 109/L and from these in 15.3% of patients dissemi-
nated candidiasis was proved, which matches with the
research’s results. According to EORTC instructions from
1989, the usage of empiric antifungal therapy in neu-
tropenic patients with fever lasting more than 5 days af-
ter applied antibiotic therapy, decreases the possibility of
expansion of invasive fungal infections. In the research13
have proved that 35% of patients had antifungal therapy
before confirmed fungal infection. In our research, in the
group of patients who did not have antifungal therapy
11.9% of patients had positive hemoculture. In the group
of patients who had antifungal therapy 11.1% of patients
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Fig. 7. ROC analysis of diagnostic values of mannan antigen for
prediction of positivity of hemoculture to Candida species.
had positive hemoculture, which was statistically insig-
nificant. The cause of this result lies in the fact that most
authors, according to the literature data, recomend for
antifungal prophylaxis amfotericin B and nystatin while
our patients had flukonazol and nystatin prophylaxis. It
was hard to do statistical analysis due to the low number
of patients positive to hemoculture in the whole group.
Statistically, more patients with positive antigen was
found among the patients who did not have antifungal
therapy (66.7%) in comparison to patients who had anti-
fungal therapy (6.7%). There was not any significant dif-
ference in the presence of antibodies among the exam-
ined groups. Our results show positive effect of antifungal
prophylaxis from preventing disseminated candidiasis.
Due to the lack of specific signs and symptoms, dissemi-
nated candidiasis represents diagnostic and therapeutic
problem16. Although hemoculture represents 'the golden
standard' for disseminated candidiasis diagnose it also
shows low sensitivity which goes around 50% and it usu-
ally takes several days to show detectable growth of
Candida17. In the group of patients with clinical signs of
disseminated candidiasis, 20% of patients had positive
hemoculture. In the group of patients without clinical
signs of disseminated candidiasis 3.3% of patients had
positive hemoculture. The reason for low sensitivity is
related to insufficient number of blood samples per one
patient. Lately quick diagnostic tests, which at the begin-
ning did not show high sensitivity and specificity, have
developed. Diagnostic methods for detecting antibodies
should differentiate candidal colonization of mucosa
membranes or superficial tissue infections from candi-
demia, which requires antifungal therapy18. Specificity of
antibodies detection tests can be low, due to the high
titra in patients with colonized candida. The test can be
with low sensitivity because the response of antibodies in
immunocompromissed patients can be postponed, de-
creased or it even can disappear19. In order to improve
sensitivity and specificity in detection of antibodies stan-
dard technique ELISA (Platelia Candida Ab) is used. An-
alyzing one serum sample per patient decreases the pos-
sibility to detect disseminated candidiasis, while analy-
zing more serum samples enables monitoring movement
of titra antigen20. Sensitivity of anti-mannan and anti-
bodies test was 47% and specificity was 100% with sam-
ple values cut-off >10 AU/mL. The level of antibodies
from 15 positive serum samples was from 10.6 to 35
(X±SD=19.81±8.05) AU/mL21. In our research we took
one serum sample per patient and average value of titra
antibodies in patients with positive hemoculture to Can-
dida was 20.7±16.1. The average value of titra antibod-
ies in patients with negative hemoculture was 13.7±
15.5, which was not statistically significant (p=0.94). In
our research average values of antibodies were higher
(p<0.05) in the group of patients with clinical signs of
disseminated candidiasis (15.85±16.24), in comparison
to the group of patients without clinical signs of dissemi-
nated candidiasis (13.24±15.0). The difference was not
large so we can conclude that values of antibodies can be
increased in patients without disseminated candidiasis
since the positive result can be colonization indicator.
Mannan is the most important manoprotein of cell wall
in Candida species. ELISA test enables disseminated
candidiasis diagnose by detection of a-oligo mannose
from serum which is released from cell walls during
Candida infection. This test has good specificity but has
to be repeated frequently because of the rapid clearance
of mannan antigen from circulation8. Test sensitivity de-
pends on the number of samples taken from each pa-
tient. In this research, sensitivity of mannanemia de-
creases from 40 to 11% if only one sample is examined
per patient. The quantity of mannan antigen in serum of
patients with positive hemoculture was from 0.5 to 3.19
ng/ml, (X±SD=1.29±0.88), sensitivity of the test was
41% and the specificity of the test was 100%21. The re-
search we took showed that the average value of titra an-
tigen (0.86±1.05) was statistically higher (p<0.001) in
patients with positive hemoculture, in comparison to pa-
tients with negative hemoculture (0.13±0.45). The ap-
proximate difference was 0.73 (%95CI = 0.30–1.17). Sen-
sitivity of the test to mannan antigen was 57% and
specificity was 98%. This values were simmilar to the val-
ues of Alam et al., since the same serological tests were
used. After performing correlation test between hemo-
culture and mannan antigen and antibodies results in
patients with clinical signs of disseminated candidiasis,
statistically significant correlation was found (r=0.36;
p<0.05), while the correaltion between hemoculture and
antibodies was insignificant (r=0.25; p=0.19). According
to our results and literature data detection of mannan
antigen is more sensitive and faster method for dissemi-
nated candidiasis diagnose in comparison to hemocultu-
re. New strategies for disseminated candidiasis diagnose
combine determining values of manan antigen and anti-
bodies in the serum applying ELISA technique (Platelia
Candida Ag and Platelia Candida Ab). Retrospective
studies have shown that sensitivity of these tests is 80 to
100%9–19,22. Combined use of both tests increases sensi-
tivity from 80% to 95,4 and specificity from 52.6 to 93%23.
In our research the number of patients who were positive
to antigen and antibodies was higher (p<0.01) in the
group of patients with clinical signs of disseminated
candidiasis (23.3%), in comparison to the group of pa-
tients without clinical signs of disseminated candidiasis
(0%). The number of patients who were positive to anti-
gen and antibodies was higher (p<0.01) in the group of
patients with positive hemoculture (42.9%),in compari-
son to the group of patients with negative hemoculture
(7.5%). Mannan antigen detection serological tests have
high negative predictive value (NPV) from 97%8. These
high values, according to authors, are good indicators of
Candidal infections and they are very useful in indeti-
fication of patients who need antifungal therapy. During
our research ROC analysis for diagnostic values of man-
nan antigen in prediction to positive hemoculture to
Candida species was performed and NPV was 96%, while
PPV(positive predictive value) was 67%. Due to the low
sensitivity of hemoculture and the time needed for isola-
tion of Candida spp., introducing serological tests into
regular procedures would speed disseminated candidiasis
diagnose.
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ZNA^AJ PRIMJENE SEROLO[KIH TESTOVA U DIJAGNOSTICI DISEMINIRANE KANDIDIJAZE
S A @ E T A K
Diseminirana kandidijaza je definirana kao gljivi~na multiorganska infekcija uzrokovana kvasnicom iz roda Can-
dida sa ili bez kandidemije. U~estalost diseminirane kandidijaze raste sa porastom broja imunokompromitiranih boles-
nika. Posljednjih nekoliko desetlje}a u~estalost diseminirane kandidijaze je u porastu kao i stopa mortaliteta. Cilj ovog
istra`ivanja je pokazati zna~aj primjene serolo{kih testova u dijagnostici diseminirane kandidijaze. Radi se o prospek-
tivnoj studiji u koju je uklju~eno 60 pacijenata oboljelih od malignih oboljenja sa i bez klini~kih znakova diseminirane
kandidijaze i 30 zdravih osoba koji ~ine kontrolnu grupu. Svim pacijentima smo pored kemokulture odre|ivali pri-
sustvo manan antigena i odgovaraju}ih antitijela C. species primjenom komercijalnog ELISA testa. U ovom istra`ivanju
obra|eni su svi, prema dostupnoj literaturi, relevantni faktori za nastanak diseminirane kandidijaze. Ovo istra`ivanje
je pokazalo da je u grupi pacijenata sa klini~kim znacima diseminirane kandidijaze zna~ajno vi{e ispitanika sa pozi-
tivnom kemokulturom na Candidu species, nego u grupi pacijenata bez klini~kih znakova kandidijaze. Broj ispitanika
koji su bili pozitivni i na antigen i antitijelo je bio zna~ajno ve}i (p<0,01) u grupi ispitanika sa klini~kim znacima
diseminirane kandidijaze (7/30; 23,3%), nego u grupi ispitanika bez istih (0/30; 0%). Prosje~na vrijednost titra antigena
je bila statisti~ki zna~ajno vi{a (p<0,001) u ispitanika sa pozitivnom, nego u onih sa negativnom kemokulturom. U
grupi ispitanika sa klini~kim znacima diseminirane kandidijaze na|eno je ukupno 6/30 (20%) ispitanika sa pozitivnom
kemokulturom na Candidu, dok je u grupi ispitanika bez klini~kih znakova na|eno 1/30 (3,3%), a {to je bilo zna~ajno
vi{e (p<0,05). Korelacijom nalaza kemokulture sa nalazom manan antigena i antijela u ispitanika sa diseminiranom
kandidijazom na|ena je statisti~ki zna~ajna korelacija, dok korelacija izme|u nalaza kemokulture i antijela nije zna-
~ajna. Zbog niske osjetljivosti kemokulture i potrebnog vremena za izolaciju Candidae spp., uvo|enje serolo{kih testova
u redovnu proceduru znatno bi ubrzalo postavljanje dijagnoze diseminirane kandidijaze.
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